GNS561
Showing 1 - 7 of 7
Cholangiocarcinoma Trial (GNS561 + Trametinib)
Not yet recruiting
- Cholangiocarcinoma
- GNS561 + Trametinib
- (no location specified)
May 22, 2023
Primary Liver Cancer Trial in Marseille (GNS561 oral tablets and capsules)
Not yet recruiting
- Primary Liver Cancer
- GNS561 oral tablets and capsules
-
Marseille, FranceGenoscience Pharma
Apr 25, 2022
Hepatocellular Carcinoma, Cholangiocarcinoma, Intrahepatic Trial in Belgium, France, United States (GNS561)
Terminated
- Hepatocellular Carcinoma
- Cholangiocarcinoma, Intrahepatic
- GNS561
-
New York, New York
- +4 more
Apr 25, 2022
COVID-19 Trial in Marseille (GNS561)
Recruiting
- COVID-19
- GNS561
-
Marseille, FranceGenoscience Pharma
Jul 27, 2021
SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor
Completed
- SARS-CoV-2 (COVID-19) Infection
- Advanced or Metastatic Hematological or Solid Tumor
- Autophagy inhibitor (GNS651)
- +3 more
-
Lyon, Rhône, France
- +11 more
Sep 29, 2022
Caregiver Distress, Physical Function, Quality of Life Trial in Houston (Baduanjin Qigong, Community-based, Baduanjin Qigong,
Active, not recruiting
- Caregiver Distress
- +2 more
- Baduanjin Qigong, Community-based
- Baduanjin Qigong, Internet-based
-
Houston, TexasUniversity of Houston
Dec 9, 2021
Cardiovascular Diseases, Diabetes, Dyslipidemias Trial in Granada (exercise)
Completed
- Cardiovascular Diseases
- +4 more
- exercise
-
Granada, Andalucía, SpainDepartment of Physiology, Faculty of Farmacy, University of Gran
Oct 24, 2016